Kala Pharmaceuticals' Series B - II Round

Kala Pharmaceuticals raised a round of funding on August 19, 2015.

Kala Pharmaceuticals (NASDAQ: KALA) is developing medicines that have the ability to rapidly and effectively penetrate mucosal barriers resulting in therapeutic efficacy and transformative treatment o…

Articles about Kala Pharmaceuticals' Series B - II Round: